Mark Sorenson

Nirsum Laboratories, Inc.

NIH Rank #1192
  • Program Leader
  • Top 10% Funded
  • Early Career

NIH Funding · FY2024

Total Funding
$4.8M
Fiscal year 2024
Grants Awarded
1
Active NIH grants
National Rank
#1,192
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $4.8M across 1 grant · National rank #1192.

Top grants by award amount

Mark Sorenson's NIH grant portfolio, ranked by award amount.

  • 1U01DA061643-01U01
    Select Late-Stage CMC, Non-clinical Studies, and Quality Programs to Accelerate NRS-033 Towards Pivotal Studies and Registration in Opioid Use Disorder
    $4.8M
    award amount

Affiliation

Institutions that have administered grants for Mark Sorenson.

Affiliated with Nirsum Laboratories, Inc. (NY).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Nirsum Laboratories, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #1192
  6. 2024
    Entered Top 25% Nationally
    Ranked #1192
  7. 2024
    Entered Top 10% Nationally
    Ranked #1192

Related investigators

Other NIH-funded PIs frequently associated with Mark Sorenson.